# Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

> **NCT04715022** · PHASE1,PHASE2 · RECRUITING · sponsor: **University of Kansas Medical Center** · enrollment: 23 (estimated)

## Conditions studied

- Hypertension
- Cardiovascular Diseases

## Interventions

- **DRUG:** Ascorbic acid solution (American Regent Laboratories Inc.)
- **DRUG:** Saline

## Key facts

- **NCT ID:** NCT04715022
- **Lead sponsor:** University of Kansas Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-17
- **Primary completion:** 2026-08-01
- **Final completion:** 2027-08-01
- **Target enrollment:** 23 (ESTIMATED)
- **Last updated:** 2025-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04715022

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04715022, "Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04715022. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*